Unlocking the "Dark Matter" of the Brain: Salk Institute Unveils First Microprotein Atlas for Alzheimer’s Research
For decades, the field of neurobiology has operated under a constrained vision of the human proteome. When researchers mapped the...
For decades, the field of neurobiology has operated under a constrained vision of the human proteome. When researchers mapped the...
For decades, the medical community has operated under a clear, albeit incomplete, understanding of shingles. The varicella zoster virus (VZV)—the...
In a significant leap forward for neurogenetics, a research team led by scientists at the University of British Columbia (UBC)...
Introduction: Scaling the Future of Bio-Based Chemistry In a significant move to solidify its position at the vanguard of the...
The delicate balance of the human respiratory microbiome is often invisible until it is disrupted. Streptococcus pneumoniae, a bacterium that...
Novartis, the Swiss pharmaceutical titan, is currently grappling with more than just the $30 billion evaporation of its market capitalization...
As artificial intelligence (AI) transitions from a futuristic concept to a daily operational utility, the life sciences industry stands at...
In a groundbreaking study that challenges our fundamental understanding of how the body responds to oncology therapies, researchers from the...
In a move that underscores its deepening entrenchment in the global biopharmaceutical supply chain, Samsung Biologics has announced a significant...
In a significant move that underscores the ongoing evolution of biopharmaceutical manufacturing, Transcenta Therapeutics has announced a strategic licensing agreement...
In a significant leap forward for regenerative medicine and immunology, a collaborative team of researchers from Georgia Institute of Technology...
For decades, the field of neuroscience has been haunted by a fundamental limitation: the "observation gap." While the most devastating...